Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative


News provided by

DP Technology

Apr 29, 2024, 03:31 ET

Share this article

Share toX

Share this article

Share toX

BEIJING, April 29, 2024 /PRNewswire/ -- In recent years, the rapid development of artificial intelligence has introduced new possibilities across numerous scientific disciplines. As an AI for Science pioneer, DP Technology is continually collaborating with partners to explore the transformative impact AI can bring to science. During its DevDay held in Beijing on April 12th, DP Technology showcased a series of large science models, including the DPA large atomic model[1], Uni-Mol 3D molecular model[2], Uni-Fold protein folding model[3], Uni-RNA ribonucleic acid model[4], and Uni-SMART large language model for multimodal scientific literature[5] among others.

Continue Reading

DPA

The rapid development of artificial intelligence (AI) is driving significant changes in the field of atomic modeling, simulation, and design. Inspired by recent advancements of large language models, DP aspires to develop a similar foundational model for the atomic domain. Developed by DP and collaborators, DPA is a large pre-trained model for interatomic potential with attention mechanism. The recently released DPA-2 model addresses the limitations of single-source DFT data reliance in other pre-trained atomistic models. DPA-2 covers ~100 elements in the periodic table. In a perovskite study, Liu Shi's team at Westlake University utilised the pre-trained DPA increased the efficiency of force field development by 100x. 

DPA-2 is also used in drug discovery. The latest version of Uni-FEP (free energy perturbation) can now be powered by DPA's pre-trained inter-atomic potential. Uni-FEP now utilizes the DPA-2 pre-trained model to optimize classical force field parameters on-the-fly, providing enhanced free energy predictions. This results in improved R^2 values and reduced RMSE.

Uni-Mol

Uni-Mol, a pre-trained 3D molecular representation learning model (ICLR '23), now boasts an improved accuracy in predicting these binding poses with over 77% of ligands achieving an RMSD value under 2.0 Å and over 75% passing all quality checks. This marks a substantial leap from the 62% accuracy of the previous version, also eclipsing other known methods. It effectively tackled common challenges like chirality inversions and steric clashes, ensuring that predictions are not just accurate but also chemically viable.

Based on Uni-Mol, VD-Gen[6], developed by DP and collaborators, is capable of directly generating molecules with high binding affinity within the protein pocket. VD-Gen accurately predicts the elemental types and fine-grained atomic coordinates of the generated molecules without the need to coarse-grain the atomic coordinates into a grid, offering higher precision compared to three-dimensional grid-based methods. Furthermore, VD-Gen can efficiently generate all types of atoms and their coordinates simultaneously, outperforming autoregressive generation models in performance without being affected by the order of generation.

Uni-QSAR[7], built on the Uni-Mol model, is an innovative tool for automated prediction of molecular properties. It can rapidly and cost-effectively assess ADMET properties during the early stages of drug development. This method utilizes the three-dimensional structural information of molecules, combined with computational chemistry and bioinformatics tools, to predict the behavior of drug molecules in the body. DP demonstrated benchmarks include 22 ADMET public datasets from the TDC Benchmark and 30 activity datasets from the MoleculeACE Benchmark with Chemprop, DeepAutoQSAR, and DeepPurpose as baselines. Uni-QSAR achieved the best performance in 21 out of 22 tasks in the TDC ADMET Benchmark tests and in 26 out of 30 tasks in the MoleculeACE benchmark tests.

Uni-RNA

Uni-RNA is pre-trained on approximately one billion high-quality RNA sequences, covering virtually all RNA space. By fine-tuning the model across a broad range of downstream tasks, Uni-RNA achieved leading results in all three RNA domains: RNA structure prediction, mRNA sequence property prediction, and RNA function prediction.

Through a research conducted by DP, it is found that out of 10 RNA sequences generated by Uni-RNA, each one surpassed the performance level of the commercially available vaccine sequences from Moderna, while being generally comparable and sometimes exceeding the level of BioNTech's commercial mRNA vaccine sequence. This demonstrates that models like Uni-RNA not only hold immense value for academic research but also possess significant potential for industrial research and development applications.

Uni-Fold

Protein structure modeling is a prerequisite for structure-based drug development. Once a preliminary structure is obtained, further refining and optimizing key structural regions is crucial for ensuring the accuracy of subsequent research.

Uni-Fold is the first protein structure prediction tool to fully open-source its training and inference code. It supports the structural prediction of polymeric protein systems and achieves top industry accuracy in prediction results under the same training datasets.

Uni-SMART

Uni-SMART (Science Multimodal Analysis and Research Transformer) tackles the urgent need for new solutions that can fully understand and analyze multimodal content in scientific literature. Indeed, many LLMs can already ingest PDF, but they often struggle to digest and interpret the rich information encapsulated within charts, graphs, and molecular structures embedded within those documents.

Through rigorous quantitative evaluation, Uni-SMART demonstrates significant performance gain in interpreting and analyzing multimodal contents in scientific documents, such as tables, charts, molecular structures, and chemical reactions, compared with other leading tools, such as GPT-4 and Gemini.

Industrial Software for Drug Discovery, Battery Development and beyond

Advancing AI for Science, DP Technology has developed a suite of industry applications based on its large science models and advanced algorithms. This suite includes the innovative Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms support a robust foundation for industrial innovation within an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, materials science, and information technology.

Open Science initiative

At DevDay, DP Technology joined forces with industry leaders such as CATL, Yunnan Baiyao, Alibaba Cloud, Tencent Cloud, Volcano Engine, China Unicom etc, to initiate an AI for Science open science ecosystem. This cross-industry collaboration aims to integrate the strengths of each party in artificial intelligence, cloud computing, and industry applications to propel innovation. The initiative aims to accelerate the open-source development of datasets, algorithms, code and pre-trained models.

Sun Weijie, founder and CEO of DP Technology, stated, "The launch of large science models is our firm commitment to advancing scientific and industrial innovation. With this series of scientific large models, we are not only able to accelerate the process of scientific research and product development but also increase the success rate of R&D, bringing disruptive impacts to drug discovery, battery development and beyond."

About DP Technology

DP Technology is a global leader in the "AI for Science" research paradigm,  where AI learns scientific principles and data, then tackles key challenges in  scientific research and industrial R&D.

DP's commitment to interdisciplinary research has led to the creation of the "DP Particle Universe," an array of pre-trained large science models  designed to bridge foundational research with practical industrial applications.  DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and  Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in  science, fostering advancements in key areas such as drug discovery, energy,  material science, and information technology.

More:https://www.dp.tech/en

Business:[email protected]

Media:[email protected]

Reference:

[1] https://arxiv.org/abs/2312.15492 

[2] https://openreview.net/forum?id=6K2RM6wVqKu 

[3] https://www.biorxiv.org/content/10.1101/2022.08.04.502811v3.full 

[4] https://www.biorxiv.org/content/10.1101/2023.07.11.548588v1 

[5] https://arxiv.org/pdf/2403.10301.pdf 

[6] https://arxiv.org/abs/2302.05847 

[7] https://arxiv.org/abs/2304.12239

SOURCE DP Technology

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months

RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months

In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a...

DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation

Lepu Biopharma Co., Ltd. (Lepu Biopharma) and Beijing DP Tech Co., Ltd. (DP Technology) have recently announced a significant milestone in their...

More Releases From This Source

Explore

Artificial Intelligence

Artificial Intelligence

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Cloud Computing/Internet of Things

Cloud Computing/Internet of Things

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.